Parameters influencing the efficiency of the thymidine kinase/ganciclovir strategy in human glioblastoma cell lines

Stereotactic and Functional Neurosurgery

Volumn 68, Issue 1-4, 1997, Pages 252-257

  Sturtz, Franck G ^a,c   Waddell, Karen ^a   Shulok, Janine ^a   Chen, Xiaozhuo ^a   Ralph Snodgrass, H ^a   Platika, Doros ^b  

^a Progenitor Inc   (United States)

^b Ontogeny Inc   (United States)

^c Progenitor Inc   (United States)

Author keywords

Ganciclovir; Gene therapy; Glioblastoma; Tumor growth

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

CANCER CELL DESTRUCTION; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; GENE THERAPY; GENETIC TRANSFECTION; GLIOBLASTOMA; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; VIRUS GENE;

ANIMALS; GANCICLOVIR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLIOBLASTOMA; HUMANS; RATS; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031395232     PISSN: 10116125     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099934     Document Type: Conference Paper

References (8)

1. Moolten FL, Wells JM: Curability of tumors bearing herpes thymidine kinase gene transfected by retroviral vectors. J Natl Cancer Inst 1990;82:297-300.
2. Ezzedine ZD, Martuza RL, Platika D, Short MP, Malick A, Choi B, Breakfield XO: Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol 1991;3:608-614.
3. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992;256: 1550-1552.
4. Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF: Clinical protocol: Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993;4:39-69.
5. Ram Z, Culver K, Oshiro E, Viola J, DeVroom H, Otto E, Long Z, McGarrity G, Muul L, Katz D, Blaese RM: Summary of results and conclusions of the gene therapy of malignant brain tumors: Clinical study J Neurosurg 1995;82:343A.
6. Beck C, Cayeux S, Lupton SD, Dörken B, Blankenstein T: The thymidine kmase/ganciclovir-mediated 'suicide' effect is variable in different tumor cells. Hum Gene Ther 1995;6:1525-1530.
7. Chen X, Li Y, Xiong K, Wagner TE: A self-initiating eukaryotic transient gene expression system based on cotransfection of bacteriophage T7 RNA polymerase and DNA vectors containing a T7 autogene. Nucleic Acids Res 1994;22:2114-2120.
8. Chen X, Li Y, Xiong K, Xie Y, Aizicovici S, Snodgrass R, Wagner TE, Piatika D: A novel nonviral cytoplasmic gene expression system and its implications in cancer gene therapy. Cancer Gene Ther 1995;2:281-289.